Showing results (291-300 of 981) with videos related to
Sort By:
Pageof 99
Cardiovascular Therapeutics|November 26, 2016
Extended dual antiplatelet therapy after acute coronary syndrome in Spain: Results from the EPICOR studyAlfredo Bardají, Manuel Leal, Vicente Arrarte, et al.Cardiovascular Therapeutics|December 14, 2016
Optimal pharmacological treatment and adherence to medication in secondary prevention of cardiovascular events in Spain: Results from the CAPS studyAlberto Cordero, Luis Rodriguez Padial, Alberto Batalla, et al.Cardiovascular Therapeutics|December 14, 2016
Protective effects of low-dose rosuvastatin on isoproterenol-induced chronic heart failure in rats by regulation of DDAH-ADMA-NO pathwayRu Zhou, Ping Ma, Aiqin Xiong, et al.Cardiovascular Therapeutics|February 6, 2014
Melatonin reduces tachycardia in postural tachycardia syndrome: a randomized, crossover trialElizabeth A Green, Bonnie K Black, Italo Biaggioni, et al.Cardiovascular Therapeutics|January 28, 2017
Implantable cardioverter defibrillators for primary prevention in patients with nonischemic cardiomyopathy: A systematic review and meta-analysisTamer Akel, James LaffertyCardiovascular Therapeutics|February 11, 2017
Enhanced mRNA expression of plasminogen activator inhibitor-1 in livedoid vasculopathy lesionsMehmet Agirbasli, Fatih Göktay, Irem Peker, et al.Cardiovascular Therapeutics|April 10, 2017
Comparisons of cardioprotective efficacy between fibroblast growth factor 21 and dipeptidyl peptidase-4 inhibitor in prediabetic ratsPongpan Tanajak, Piangkwan Sa-Nguanmoo, Nattayaporn Apaijai, et al.Cardiovascular Therapeutics|May 27, 2015
Optimal Duration of Dual Antiplatelet Therapy after Drug-Eluting Stents: Meta-Analysis of Randomized TrialsElsayed Abo-Salem, Said Alsidawi, Hina Jamali, et al.Cardiovascular Therapeutics|May 15, 2015
TPEN prevents rapid pacing-induced calcium overload and nitration stress in HL-1 myocytesShusen Yang, Wenjing Xu, Zengxiang Dong, et al.Cardiovascular Therapeutics|April 21, 2015
Eptifibatide in post-infarction angina patients who refused intervention: Ajmer postmyocardial infarction angina eptifibatide research (AJMER) study: a pilot studyRajendra Gokhroo, Kamal Kishor, Bhanwar Ranwa, et al.Pageof 99